AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Sidwell, RW Smee, DF Huffman, JH Barnard, DL Morrey, JD Bailey, KW Feng, WC Babu, YS Bush, K
Citation: Rw. Sidwell et al., Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201, ANTIVIR RES, 51(3), 2001, pp. 179-187

Authors: Bantia, S Parker, CD Ananth, SL Horn, LL Andries, K Chand, P Kotian, PL Dehghani, A El-Kattan, Y Lin, T Hutchison, TL Montgomery, JA Kellog, DL Babu, YS
Citation: S. Bantia et al., Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir, ANTIM AG CH, 45(4), 2001, pp. 1162-1167

Authors: Sidwell, RW Smee, DF Huffman, JH Barnard, DL Bailey, KW Morrey, JD Babu, YS
Citation: Rw. Sidwell et al., In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201, ANTIM AG CH, 45(3), 2001, pp. 749-757

Authors: Chand, P Kotian, PL Dehghani, A El-Kattan, Y Lin, TH Hutchison, TL Babu, YS Bantia, S Elliott, AJ Montgomery, JA
Citation: P. Chand et al., Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity, J MED CHEM, 44(25), 2001, pp. 4379-4392

Authors: Babu, YS Chand, P Bantia, S Kotian, P Dehghani, A El-Kattan, Y Lin, TH Hutchison, TL Elliott, AJ Parker, CD Ananth, SL Horn, LL Laver, GW Montgomery, JA
Citation: Ys. Babu et al., BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active,and selective influenza neuraminidase inhibitor through structure-based drug design, J MED CHEM, 43(19), 2000, pp. 3482-3486

Authors: Szalai, AJ Digerness, SB Agrawal, A Kearney, JF Bucy, RP Niwas, S Kilpatrick, JM Babu, YS Volanakis, JE
Citation: Aj. Szalai et al., The Arthus reaction in rodents: Species-specific requirement of complement, J IMMUNOL, 164(1), 2000, pp. 463-468

Authors: Narayana, SVL Babu, YS Valanakis, JE
Citation: Svl. Narayana et al., Inhibition of complement serine proteases as a therapeutic strategy, CONT IMMUN, 9, 2000, pp. 57-74

Authors: Atigadda, VR Brouillette, WJ Duarte, F Babu, YS Bantia, S Chand, P Chu, NM Montgomery, JA Walsh, DA Sudbeck, E Finley, J Air, GM Luo, M Laver, GW
Citation: Vr. Atigadda et al., Hydrophobic benzoic acids as inhibitors of influenza neuraminidase, BIO MED CH, 7(11), 1999, pp. 2487-2497

Authors: Brouillette, WJ Atigadda, VR Duarte, F Luo, D Air, GM Babu, YS Bantia, S
Citation: Wj. Brouillette et al., Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping (vol 9, pg 1901, 1999), BIOORG MED, 9(22), 1999, pp. 3259-3259

Authors: Brouillette, WJ Atigadda, VR Luo, M Air, GM Babu, YS Bantia, S
Citation: Wj. Brouillette et al., Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping, BIOORG MED, 9(14), 1999, pp. 1901-1906

Authors: Atigadda, VR Brouillette, WJ Duarte, F Ali, SM Babu, YS Bantia, S Chand, P Chu, N Montgomery, JA Walsh, DA Sudbeck, EA Finley, J Luo, M Air, GM Laver, GW
Citation: Vr. Atigadda et al., Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent, J MED CHEM, 42(13), 1999, pp. 2332-2343
Risultati: 1-11 |